AMICUS THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Amicus Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Amicus Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 299M shares, a 2.76% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 299M +8.02M +2.76% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 296M +9.44M +3.29% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 296M +12.9M +4.54% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 294M +12.5M +4.44% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 291M +9.78M +3.48% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 287M +6.54M +2.33% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 283M +3.17M +1.13% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 281M +2.2M +0.79% Dec 31, 2022 10-K 2024-02-28
Q3 2022 281M +2.3M +0.83% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 280M +13.9M +5.22% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 280M +14.1M +5.31% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 279M +16.8M +6.43% Dec 31, 2021 10-K 2023-03-01
Q3 2021 279M +19M +7.31% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 267M +8.31M +3.22% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 266M +8.56M +3.32% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 262M +6.65M +2.6% Dec 31, 2020 10-K 2022-02-24
Q3 2020 260M +4.83M +1.9% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 258M +3.71M +1.46% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 257M +27.3M +11.8% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 255M +66M +34.9% Dec 31, 2019 10-K 2021-03-01
Q3 2019 255M +65.5M +34.6% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 255M +65.5M +34.6% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 230M +42.2M +22.5% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 189M +22.4M +13.4% Dec 31, 2018 10-K 2020-03-02
Q3 2018 189M +23.8M +14.4% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 189M +45.7M +31.9% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 188M +45.1M +31.6% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 167M +24.3M +17% Dec 31, 2017 10-K 2019-02-28
Q3 2017 165M +23.2M +16.3% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 143M +8.96M +6.67% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 143M +17.6M +14.1% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 143M +17.7M +14.1% Dec 31, 2016 10-K 2018-03-01
Q3 2016 142M +17.7M +14.2% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 134M +16M +13.6% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 125M +28.8M +29.9% Mar 31, 2016 10-Q 2016-05-03
Q4 2015 125M +29.5M +30.8% Dec 31, 2015 10-K/A 2017-03-03
Q3 2015 125M +45.4M +57.2% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 118M +45.5M +62.4% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 96.4M +32M +49.8% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 95.6M +33.6M +54.2% Dec 31, 2014 10-K 2016-02-29
Q3 2014 79.3M +29.6M +59.7% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 72.9M +23.2M +46.8% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 64.3M +14.7M +29.6% Mar 31, 2014 10-Q 2014-05-05
Q4 2013 62M +12.3M +24.9% Dec 31, 2013 10-K 2015-03-03
Q3 2013 49.6M +271K +0.55% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 49.6M +3.25M +7.02% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 49.6M +3.26M +7.02% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 49.6M +15M +43.2% Dec 31, 2012 10-K 2014-03-03
Q3 2012 49.4M +14.7M +42.4% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 46.4M +11.8M +34.1% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 46.4M Mar 31, 2012 10-Q 2012-05-11
Q4 2011 34.7M +145K +0.42% Dec 31, 2011 10-K 2014-03-03
Q3 2011 34.7M Sep 30, 2011 10-Q 2011-11-02
Q2 2011 34.6M Jun 30, 2011 10-Q 2011-08-11
Q4 2010 34.5M Dec 31, 2010 10-K 2012-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.